Policies & Disclaimers  |  Contact Us  |  Site Map  |  Important Safety Information   
Inhaled Ventavis® (iloprost) Inhalation Solution Breathe In Your Second Chance For Patients with Pulmonary Arterial Hypertension with NYHA Class III or IV Symptoms
Resources
Ventavis Patient Stories
I-neb AAD Learning Center
PAH Learning Center
PAH Pathways - Actelion Services & Support

Resources

This section contains downloadable brochures as well as registration forms for support programs. Please check back often to view newly updated support materials for those living with pulmonary arterial hypertension.

  • Once-A-Day Cleaning Brochure
  • Ventavis® (iloprost) Patient Brochure
  • I-neb AAD System User Guide
  • ABCs of Ventavis brochure
  • Partnership Promise brochure
  • I-neb Is My Neb brochure
    		•


    IMPORTANT SAFETY INFORMATION:
    Because it lowers your blood pressure, Ventavis may cause dizziness, lightheadedness, and fainting. With Ventavis, the most common side effects are reddening of the face caused by dilation of blood vessels (flushing), increased cough, low blood pressure (hypotension), headaches, nausea, spasm of the jaw muscles that causes trouble opening your mouth, and fainting (syncope); other serious adverse events reported with the use of Ventavis include congestive heart failure, chest pain, supraventricular tachycardia, dyspnea, peripheral edema, and kidney failure. Before you start taking Ventavis, talk to your doctor to make sure you understand the side effects you might get.

    The I-neb AAD System is a registered trademark of Philips Respironics.

    Please see full Prescribing Information

    For more information about
    Ventavis, please call
    1-866-ACTELION (1-866-228-3546).

    Policies & Disclaimers  |  Contact Us   |  Site Map  |  Important Safety Information

    THIS SITE IS INTENDED FOR U.S. AUDIENCES ONLY.
    SECOND WIND is a licensed trademark of Pulmonary Rehabilitation Associates.
    ©2010 Actelion Pharmaceuticals US, Inc. All rights reserved.

    		ACTELION